Janiczek Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Janiczek Wealth Management's BMY Position: Q2 2024 in Review
Janiczek Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2024, selling an estimated $20.6K and leaving 1,840 shares worth $76.4K. The position accounts for 0.02% of the portfolio, ranked #336.
Janiczek Wealth Management first reported a position in BMY in Q2 2020 and has held it in 17 quarters since. The position peaked at $185K in Q4 2023. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- Janiczek Wealth Management held 1,840 shares of Bristol-Myers Squibb worth $76.4K as of Q2 2024.
- Janiczek Wealth Management sold 461 Bristol-Myers Squibb shares in Q2 2024, an estimated $20.6K.
- Bristol-Myers Squibb made up 0.02% of Janiczek Wealth Management's portfolio in Q2 2024, its #336 holding.
- Janiczek Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 17 quarters since.
- Janiczek Wealth Management's Bristol-Myers Squibb position peaked at $185K in Q4 2023.
- 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.